2,970
Views
155
CrossRef citations to date
0
Altmetric
TRENDS IN MOLECULAR MEDICINE

Hemophagocytic lymphohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives

&
Pages 20-31 | Published online: 08 Jul 2009
 

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare life‐threatening disease in which the immune system becomes overactive due to its inability to effectively respond to infections and/or shut down the immune response to such infections. The discovery of genetic defects in the secretory pathway of natural killer (NK) cells and cytotoxic T cells in some patients with this disease has raised important questions of the role of cytotoxic cells in the control of infections and in immune regulation. This review will give a brief overview of the clinical presentation and accepted treatment of HLH. Furthermore, it will give an in‐depth review into the known genetic defects and current knowledge of the pathophysiology of this disorder, and will highlight recent evidence suggesting that cytotoxic defects in CD4+ T regulatory cells may contribute to the pathogenesis of HLH.

Abbreviations
IL=

interleukin

IFN=

interferon

TNF=

tumor necrosis virus

ESR=

erythrocyte sedimentation rate

CMV=

cytomegalovirus

HHV=

human herpes virus

VSV=

Varicella zoster virus

TGF=

transforming growth factor

GTP=

guanosine triphosphate

Ras=

rat sarcoma oncogene

PBMC=

peripheral blood mononuclear cell

HSV=

herpes sinplex virus

Abbreviations
IL=

interleukin

IFN=

interferon

TNF=

tumor necrosis virus

ESR=

erythrocyte sedimentation rate

CMV=

cytomegalovirus

HHV=

human herpes virus

VSV=

Varicella zoster virus

TGF=

transforming growth factor

GTP=

guanosine triphosphate

Ras=

rat sarcoma oncogene

PBMC=

peripheral blood mononuclear cell

HSV=

herpes sinplex virus

Acknowledgements

This work was supported by the Advancing a Healthier Wisconsin program (WJG), the Hope Street Kids (WJG), and the Abbott Scholars Award in Rheumatology Research (JWV). We thank David Wilson for his critical review of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.